Patent No.: US7314612B2 Issued: 01/Jan/2008Title: Cosmetic compositions containing at least one heteropolymer and at least one gelling agent and methods of using the same
Applicant/Assignee: L'OREAL S.A
Application No.: 10/203254 Filing Date: 20/Dec/2002
Abstract:
The invention relates to a physiologically acceptable composition, in particular a cosmetic composition, containing at least one liquid fatty phase comprising at least one structuring polymer comprising a polymer skeleton having hydrocarbon-based repeating units containing at least one hetero atom, and and at least one gelling agent for the said fatty phase, the liquid fatty phase, the structuring polymer and the gelling agent forming a physiologically acceptable medium. This composition may be in the form of a stick of lipstick which is stable, which does not exude and whose application produces a glossy deposit with good staying power over time.
Priority: WO2000IB02006 Applic. Date: 2000-12-12; WO2001IB02840 Applic. Date: 2001-12-12
Inventor: FERRARI VERONIQUE [FR]; PINZON CARLOS O [US]; THAU PAUL [US]
Patent No.: US7314644B2 Issued: 01/Jan/2008Title: Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug
Applicant/Assignee: SK CHEMICALS CO., LTD
Application No.: 10/527139 Filing Date: 08/Mar/2005
Abstract:
Disclosed is a method for extracting and purifying active constituents from honeysuckle (Lonicera japonica Thunb.) and its use. More particularly, this invention relates to an extraction and purification method of active constituents including sweroside from for honeysuckle stem (stem of honeysuckle where leaves are removed) by removing tannins, hardly soluble flavonoids, saponins, and the like. Thus obtained active constituents have better anti-inflammatory and analgesic effect, are safer and more stable than the conventional active constituents obtained from honeysuckle flower or honeysuckle leaves, and include sweroside which is an effective active ingredient of anti-inflammatory and analgesic drug.
Priority: KR20020055106 Applic. Date: 2002-09-11; KR20020058494 Applic. Date: 2002-09-26; WO2003KR01851 Applic. Date: 2003-09-08
Inventor: KWAK WIE-JONG [KR]; CHO YONG-BAIK [KR]; HAN CHANG-KYUN [KR]; SHIN HEE JAE [KR]; RYU KEUN HO [KR]; YOO HUNSEUNG [KR]; RHEE HAE IN [KR]
Patent No.: US7316808B2 Issued: 08/Jan/2008Title: Phase inverted oil-in-water photoprotective emulsions comprising nanopigments of metal oxides and 4,4-diarylbutadiene UV-A sunscreens
Applicant/Assignee: L'OREAL
Application No.: 10/823640 Filing Date: 14/Apr/2004
Abstract:
Stable UV-photoprotective, phase inverted oil-in-water emulsions, well suited for the photoprotection of the skin, lips and/or hair, the average size of the globules which constitute the oily phase thereof ranging from 100 nm to 1,000 nm, contain inorganic metal oxide nanopigments and at least one organic UV-screening agent, and which also contain at least one organic 4,4-diarylbutadiene UV-A-screening agent.
Priority: FR20030004645 Applic. Date: 2003-04-14; US20030468059P Applic. Date: 2003-05-06
Inventor: CANDAU DIDIER [FR]
Patent No.: US7316809B2 Issued: 08/Jan/2008Title: Aqueous photoprotective compositions comprising diblock or triblock copolymers and 4,4-diarylbutadiene UV-A sunscreens
Applicant/Assignee: L'OREAL
Application No.: 10/823659 Filing Date: 14/Apr/2004
Abstract:
Photoprotective compositions, e.g., oil-in-water or water-in-oil emulsions, well suited for the photoprotection of the skin, lips and/or hair against the damaging effects of UV-radiation, comprise at least one aqueous phase, at least one water-soluble or water-dispersible polymer having a diblock structure A-B or a triblock structure B-A-B wherein A is an ionic water-soluble polymeric block and B is a hydrophobic polymeric block and at least one system screening out UV radiation, said at least one screening system comprising at least one 4,4-diarylbutadiene UV-A screening agent.
Priority: FR20030004646 Applic. Date: 2003-04-14
Inventor: L ALLORET FLORENCE [FR]
Patent No.: US7323436B2 Issued: 29/Jan/2008Title: Adduct having an acidic solution of sparingly-soluble group IIA complexes
Applicant/Assignee: MORNINGSTAR DIAGNOSTICS, INC MIONIX CORPORATION
Application No.: 10/223309 Filing Date: 19/Aug/2002
Abstract:
An adduct that has an acidic solution of sparingly-soluble Group IIA complexes ("AGIIS") and at least one additive. The AGIIS can be prepared by mixing a mineral acid (such as sulfuric acid), and a Group IIA hydroxide (such as calcium hydroxide) or a Group IIA salt of a dibasic acid (such as calcium sulfate), or a mixture of the two Group IIA compounds, followed by removing the solid formed. The additives can be an alcohol, an organic acid or a surface active agent. The composition has various uses, including cleaning, food production, decontamination, bioremediation, agricultural application, medical application, and detoxification of substances.
Priority: US2000-500474 Applic. Date: 2000-02-09; US1999-253241 Applic. Date: 1999-02-19
Inventor: KEMP MAURICE CLARENCE [US]; LALUM ROBERT B [US]; XIE ZHONG WEI [US]; CUNHA MICHAEL A [US]; CARPENTER ROBERT H [US]; SHU ZHANG [US]; YU YAO [US]; LEWIS DAVID E [US]
Patent No.: US7323438B2 Issued: 29/Jan/2008Title: Cleansing article with improved handleability
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY PROCTER & GAMBLE
Application No.: 10/863433 Filing Date: 08/Jun/2004
Abstract:
The present invention is directed to a disposable article that contains a plurality of substrate layers. The article is selected from the group consisting of pad sized articles, grip sized articles, sheet sized articles and combinations. These articles have a cleansing composition associated with the substrate layers. The articles provide effective cleansing benefits to the skin and hair in a convenient, inexpensive, and sanitary manner. The articles of the present invention also have superior thickness. Additionally, the article has increased rigidity while at the same time is flexible. The increase in rigidity and thickness provides for an article that does not crush or crumple during use. The article of the present invention can also provide a therapeutic or aesthetic benefit without the need for a separate benefit providing product.
Priority: US20030478631P Applic. Date: 2003-06-13
Inventor: HEDGES STEVEN KIRK [US]; SMITH III EDWARD DEWEY [US]
Patent No.: US7326182B2 Issued: 05/Feb/2008Title: Method of using device for bio-affinity material for treatment of blood or plasma
Applicant/Assignee: GLYCOREX TRANSPLANTATION AB
Application No.: 11/304364 Filing Date: 15/Dec/2005
Abstract:
Bio-affinity material containing at least one biologically active saccharide which is covalently bound via at least one spacer to a cross-linked matrix and that the material is autoclaved. Apparatus for contacting body fluids with the bio-affinity material is disclosed.
Priority: US2002-114314 Applic. Date: 2002-04-03; US1996-091486 Applic. Date: 1996-12-23; US2000-722241 Applic. Date: 2000-11-27; WO2001SE00241 Applic. Date: 2001-02-07
Inventor: NILSSON KURT G L [SE]
Patent No.: US7326405B2 Issued: 05/Feb/2008Title: Cosmetic compositions
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 10/883505 Filing Date: 01/Jul/2004
Abstract:
The method of imparting color to skin comprising applying to the skin a cosmetic compositions comprising an alpha-hydroxyaldehyde self-tanning agent and a water-soluble vitamin B3 compound as a self-tanning composition are provided. The cosmetic compositions are useful for imparting a natural, even and durable tan to the skin when topically applied.
Priority:
Inventor: CROOK TERESA BARBARA [GB]; STEPHENS ALISON FIONA [GB]
Patent No.: US7326406B2 Issued: 05/Feb/2008Title: Dual component skin care compositions that comprise a self-tanning agent
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 10/883616 Filing Date: 01/Jul/2004
Abstract:
Cosmetic kits comprising at least two separated components are provided. The at least two separated components comprise, in one component, a self-tanning agent, and in the other, a reactive skin care active. The cosmetic kits provide increased skin health benefits when both components are applied to the skin simultaneously or successively.
Priority: EP20030254235 Applic. Date: 2003-07-03
Inventor: CROOK TERESA BARBARA [GB]; STEPHENS ALISON FIONA [GB]
Patent No.: US7326407B2 Issued: 05/Feb/2008Title: Amine, amide, sulphonamide and carbamate derivatives of benzalmalonic salts and photoprotective cosmetic compositions comprised thereof
Applicant/Assignee: L'OREAL
Application No.: 11/315249 Filing Date: 23/Dec/2005
Abstract:
Stable, topically applicable cosmetic/dermatological sunscreen compositions, well suited for the UV-photoprotection of human skin/keratinous materials, contain a thus effective amount of at least one novel amine, amide, sulphonamide or carbamate substituted benzalmalonic salt compound.
Priority: FR20030002561 Applic. Date: 2003-03-03; US2004-787759 Applic. Date: 2004-02-27; US20030483652P Applic. Date: 2003-07-01
Inventor: RICHARD HERVE [FR]; LUPPI BERNADETTE [FR]
Patent No.: US7329403B2 Issued: 12/Feb/2008Title: Cosmetic compositions
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC
Application No.: 10/603318 Filing Date: 25/Jun/2003
Abstract:
Cosmetic compositions in the form of soft solids having in combination an improved resistance to syneresis and retained efficacy and which contain a particulate antiperspirant suspended in a water-immiscible carrier liquid structured by a structurant system are obtainable by employing as carrier liquid a mixture of a hydrocarbon oil and an aromatic ester oil in a weight ratio of from 1:2 to 15:1 and as structurant system from 5.5 to 20% in total of a di or triblock alkylene/arylene block copolymer and an organic wax in a weight ratio to each other of from 5:1 to 30:1.
Priority: GB20020014805 Applic. Date: 2002-06-26
Inventor: CHUAH BENG SIM [MY]; EMSLIE BRUCE STEVEN [GB]; FRANKLIN KEVIN RONALD [GB]; MARTINDALE DANIEL ALBERT [GB]; TURNER GRAHAM ANDREW [GB]
Patent No.: US7332152B2 Issued: 19/Feb/2008Title: Cosmetic composition
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC
Application No.: 10/980479 Filing Date: 03/Nov/2004
Abstract:
A cosmetic composition is provided comprising vitamin B6, vitamin B3 and an organic acid. The components of the composition interact synergistically to enhance skin lightening.
Priority: GB20040004118 Applic. Date: 2004-02-25; IN2003MU01165 Applic. Date: 2003-11-06
Inventor: SANZGIRI VIBHAV RAMRAO [IN]; SETHNA SIMONE DOSU [IN]; SHAH SHIVANI KIRAN [IN]; SONA PUSHKER [TH]
Patent No.: US7332153B2 Issued: 19/Feb/2008Title: Cosmetic compositions
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC
Application No.: 10/346646 Filing Date: 17/Jan/2003
Abstract:
Cosmetic formulations containing a cosmetic active and a continuous phase comprising a water-immiscible liquid carrier, such as, amongst other materials, silicone oils, branched aliphatic alcohols or liquid aromatic/aliphatic esters that is structured by a cyclodipeptide derivative having the general formula in which RA represents a carbocyclic or heterocyclic group containing not more than 2 rings, other than unsubstituted cyclohexyl.
Priority: GB20020001164 Applic. Date: 2002-01-18; GB20020017840 Applic. Date: 2002-08-01
Inventor: BHATIA SHAMEEM [GB]; VAN ESCH JAN [NL]; FAIRCLOUGH COLETTE MARIE [GB]; FRANKLIN KEVIN RONALD [GB]; FINDLAY PAUL HUGH [GB]; WEBB NICHOLAS [GB]; WHITE MICHAEL STEPHEN [GB]
Patent No.: US7332179B2 Issued: 19/Feb/2008Title: Tissue products comprising a cleansing composition
Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC
Application No.: 10/735591 Filing Date: 12/Dec/2003
Abstract:
The present invention discloses tissue products comprising a cleansing composition. The cleansing composition removes soil and contaminants from the skin's surface and comprises a thermoplastic polymer and a water soluble neutral oligosaccharide. In one embodiment, the cleansing composition comprises polymethylmethacrylate and a water soluble starch.
Priority:
Inventor: KISTLER ANNASTACIA [US]; KOENIG DAVID M [US]; KRZYSIK DUANE G [US]; CUNNINGHAM COREY [US]
Patent No.: US7332191B2 Issued: 19/Feb/2008Title: Compositions containing toasted soybean flakes and potato flakes
Applicant/Assignee: MICROSOY CORPORATION
Application No.: 10/792955 Filing Date: 04/Mar/2004
Abstract:
The invention relates to an improved compositions comprising mixtures of toasted soybean flakes and potato flakes, for making highly soy protein enriched and soy oil containing mashed potato products having excellent nutritional, taste and texture properties. The toasted soybean flakes are made from full fat, enzyme active, dehulled soybean flakes. Additionally, the invention relates to methods for making said highly soy protein enriched and soy oil containing mashed potato products from said compositions
and to said highly soy protein enriched and soy oil containing mashed potato products per se.
Priority: US2003-382697 Applic. Date: 2003-03-06
Inventor: TANAKA ITARU TERRY [US]; MOIZUDDIN SAFIR [US]
Patent No.: US7332320B2 Issued: 19/Feb/2008Title: Protease producing an altered immunogenic response and methods of making and using the same
Applicant/Assignee: GENENCOR INTERNATIONAL, INC
Application No.: 10/498714 Filing Date: 14/Jun/2004
Abstract:
The present invention provides novel protein variants that exhibit reduced immunogenic responses, as compared to the parental proteins. The present invention further provides DNA molecules that encode novel variants, host cells comprising DNA encoding novel variants, as well as methods for making proteins less allergenic. In addition, the present invention provides various compositions that comprise these proteins that are less immunogenic than the wild-type proteins.
Priority: US20010344702P Applic. Date: 2001-12-31; WO2002US41235 Applic. Date: 2002-12-20
Inventor: ESTELL DAVID A [US]; HARDING FIONA A [US]
Patent No.: US7332472B2 Issued: 19/Feb/2008Title: Cyclosporine analogue mixtures and their use as immunomodulating agents
Applicant/Assignee: ISOTECHNIKA INC
Application No.: 11/118830 Filing Date: 28/Apr/2005
Abstract:
The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine A. The mixtures possess enhanced efficacy and reduced toxicity over the individual isomers and over naturally occurring and other presently known cyclosporines and cyclosporine derivatives. Embodiments of the present invention are directed toward cis and trans-isomers of cyclosporin A analogs referred to as ISATX247, and derivatives thereof. Mixtures of ISATX247 isomers exhibit a combination of enhanced potency and reduced toxicity over the naturally occurring and presently known cyclosporins. ISATX247 isomers and alkylated, arylated, and deuterated derivatives are synthesized by stereoselective pathways where the particular conditions of a reaction determine the degree of stereoselectivity.
The ratio of isomers in a mixture may range from about 10 to 90 percent by weight of the (E)-isomer to about 90 to 10 percent by weight of the (Z)-isomer, based on the total weight of the mixture.
Priority: US2002-274255 Applic. Date: 2002-10-17; US20010346201P Applic. Date: 2001-10-19; US20020370596P Applic. Date: 2002-04-05
Inventor: NAICKER SELVARAJ [CA]; YATSCOFF RANDALL W [CA]; FOSTER ROBERT T [CA]
Patent No.: US7332503B2 Issued: 19/Feb/2008Title: Aporphine esters and their use in therapy
Applicant/Assignee: AXON BIOCHEMICALS B.V
Application No.: 11/061881 Filing Date: 22/Feb/2005
Abstract:
New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
Priority: SE20000002934 Applic. Date: 2000-08-17; WO2001SE01658 Applic. Date: 2001-07-20; US2003-344420 Applic. Date: 2003-07-15
Inventor: WIKSTROM HAKAN [NL]; DIJKSTRA DURK [NL]; CREMERS THOMAS [NL]; ANDREN PER ERIK [SE]; MARCHAIS SANDRINE [NL]; JURVA ULRIK [NL]
Patent No.: US7335230B2 Issued: 26/Feb/2008Title: Connective tissue substitutes, method of preparation and uses thereof
Applicant/Assignee: SWABEY OGILVY RENAULT UNIVERSITE DE MONTREAL
Application No.: 09/990320 Filing Date: 23/Nov/2001
Abstract:
The present invention relates to connective tissue substitute implant and method of preparation thereof. The implant is essentially composed of two bone anchors joined at the proximal ends by matrix layers and/or filaments coated by supplementary biocompatible matrix coating layer which can contain living stem cells isolated from injured connective tissue.
Priority: US20000252588P Applic. Date: 2000-11-24
Inventor: GOULET FRANCINE [CA]; RANCOURT DENIS [CA]; CLOUTIER REJEAN [CA]; TREMBLAY JULIE [CA]; AUGER FRANCOIS A [CA]; NORMAND ALBERT [CA]; GERMAIN LUCIE [CA]; LAMONTAGNE JEAN [CA]; BOUCHARD MARC [CA]; LANGELIER EVE [CA]; DUPUIS DANIEL [CA]; BOUCHARD STEPHANE [CA]; ISLAM NAZRUL [CA]; STEVENS LOUIS-MATHIEU [CA]; LAVERTY SHEILA [CA]; LUSSIER BERTRAND [CA]; BELZIL ANNE-MARIE [CA]; TREMBLAY PIERROT [CA]
Patent No.: US7335377B2 Issued: 26/Feb/2008Title: Transdermal delivery system for dried particulate or lyophilized medications
Applicant/Assignee: TRANSPHARMA MEDICAL LTD
Application No.: 10/699582 Filing Date: 31/Oct/2003
Abstract:
The present invention provides a system for transdermal delivery of dried or lyophilized pharmaceutical compositions and methods using thereof. The system comprises an apparatus for facilitating transdermal delivery of an agent that generates hydrophilic micro-channels, and a patch comprising a therapeutically active agent. The present invention is useful for transdermal delivery of hydrophilic agents, particularly of high molecular weight proteins.
Priority: IL20020152574 Applic. Date: 2002-10-31
Inventor: STERN MEIR [IL]; LEVIN GALIT [IL]
Patent No.: US7335390B2 Issued: 26/Feb/2008Title: Composition containing soybean flakes and potato flakes, method for making a food product therefrom, and said food product
Applicant/Assignee: MICROSOY CORPORATION
Application No.: 10/382697 Filing Date: 06/Mar/2003
Abstract:
The invention relates to a composition comprising a mixture of full fat, enzyme active, dehulled soybean flakes and potato flakes, for making a soy protein enriched and soy oil containing mashed potato product having excellent nutritional, taste and texture properties. Additionally, the invention relates to method for making said soy protein enriched and soy oil containing mashed potato product from said composition
and to said soy protein enriched and soy oil containing mashed potato product.
Priority:
Inventor: TANAKA ITARU TERRY [US]; MOIZUDDIN SAFIR [US]; LIU BRUCE H T [US]
Patent No.: US7335631B2 Issued: 26/Feb/2008Title: Encapsulated perfume compositions in hair and skin products which release a burst of fragrance after initial topical application
Applicant/Assignee: SYMRISE, INC
Application No.: 10/238386 Filing Date: 09/Sep/2002
Abstract:
The present invention relates to personal treatment compositions, which contain encapsulated perfume compositions, which release a burst of fragrance a period of time after initial topical application. According to the present invention, the burst of fragrance is released with the application of mechanical pressure on the encapsulated perfume composition. Further, the present invention relates to hair and skin compositions, which release a burst of fragrance a period of time after initial topical application by rubbing the skin or brushing the hair.
Priority:
Inventor: MCDERMOTT KEITH J [US]; ZHUANG ZIJIE JUDY [US]; SMITH LESLIE C [US]
Patent No.: US7337004B2 Issued: 26/Feb/2008Title: Method and apparatus for veterinary RF pain management
Applicant/Assignee:
Application No.: 10/774742 Filing Date: 09/Feb/2004
Abstract:
A method and apparatus for reducing chronic pain in animals by radio frequency (RF) neuromodulation of peripheral nerves of the animal is disclosed. The method, using the disclosed apparatus, comprises the steps of attaching active and dispersive percutaneous probes at respective active and dispersive locations relative to a peripheral nerve of the patient associated with the pain to be reduced
generating a first pulsed RF signal for coupling to the active and dispersive probes to verify the location of the peripheral nerve
and generating a second pulsed RF signal for coupling to the active and dispersive probes to modify propagation of pain sensation in the peripheral nerve without ablation thereof.
In one embodiment of the apparatus, the active percutaneous probe includes an RF cannula having a conductive spatulate blade conformably attached to a dorsal side of a curved, blunt-ended tubular tip portion of the RF cannula. In another embodiment of the apparatus, a dispersive percutaneous probe includes a pair of 22 gauge needles connected to ground return conductors. In yet another embodiment of the apparatus, a pulsed RF generator is modified to provide specific outputs adapted to the neuromodulation of peripheral nerves in veterinary patients.
Priority:
Inventor: CLASSEN ASHLEY M [US]; REVENAUGH MARK [US]
Patent No.: US7338671B2 Issued: 04/Mar/2008Title: Skin-smoothing cosmetic based on plant extracts
Applicant/Assignee: COTY B.V
Application No.: 10/523082 Filing Date: 02/Feb/2005
Abstract:
The invention relates to a cosmetic whose active constituents are specified plant extracts and which has a very good skin-smoothing activity. According to the invention, the skin-smoothing of porous or uneven skin having macroscopically visible elevations and depressions during cosmetic processes occurs without irritating side effects. The cosmetic contains plant extracts from Bambusa vulgaris, Nymphaea alba, Poterium officinale, Zingiber officinalis, Cinnamomum cassia, Nasturtium officinale R.Br., Nelumbo nucifera Gaertn. and contains a powder selected from the group consisting of talcum powder, bamboo powder, kaolin, zinc oxide and mixtures thereof. The inventive cosmetic also contains cosmetic adjuvants, excipients, additional active substances and mixtures thereof.
Priority: WO2002DE03059 Applic. Date: 2002-08-16
Inventor: GOLZ-BERNER KARIN [MC]; ZASTROW LEONHARD [MC]
Patent No.: US7340297B2 Issued: 04/Mar/2008Title: Kit, device and method for controlled delivery of oxidizing agent into the skin
Applicant/Assignee: POWER PAPER LTD
Application No.: 10/858045 Filing Date: 02/Jun/2004
Abstract:
A kit, device and method for delivering an oxidizing agent onto and/or into the body are disclosed. Moreover, a dermal patch device, which delivers an oxidizing agent using iontophoresis and or electroosmosis onto and/or into the body is disclosed. Furthermore, use of a dermal patch device for treatment of a body area with an oxidizing agent is disclosed. The device may be a thin and flexible dermal patch. A method of using such a device/kit for treatment of a disorder of a body area with an oxidizing agent is also disclosed.
Priority: US20030474596P Applic. Date: 2003-06-02
Inventor: TAMARKIN DOV [IL]; MAVOR DANIELA [IL]; NITZAN ZVI [IL]; ARBEL GIORA [IL]; HAREL NURIT [IL]; LUSKI SHALOM [IL]; GROSS YOSSI [IL]
Patent No.: US7341712B2 Issued: 11/Mar/2008Title: Cosmetic or dermatological light-protective formulation comprising a hydroxybenzophenone and a benzoxazole derivative
Applicant/Assignee: BEIERSDORF AG
Application No.: 10/871861 Filing Date: 18/Jun/2004
Abstract:
The invention is a light-protective cosmetic or dermatological preparation, comprising (a) at least hydroxybenzophenone and (b) at least one benzoxazole derivative. The invention is also a cosmetic or dermatological preparation comprising at least one hydroxybenzophenone of a specified chemical structure and at least one benzoxazole derivative. The invention is also a method of treating or preventing cosmetic or dermatological changes in the skin, a method of tanning or accelerating tanning of the skin, and a method of protecting the skin against light-induced aging, each comprising applying the preparation to the skin. The invention also includes a wipe impregnated with the preparation.
Priority: DE20011062843 Applic. Date: 2001-12-20; DE20021049367 Applic. Date: 2002-10-23; WO2002EP14391 Applic. Date: 2002-12-17
Inventor: GOEPPEL ANJA [DE]; SCHULZ JENS [DE]; EITRICH ANJA [DE]
Patent No.: US7341737B2 Issued: 11/Mar/2008Title: Medicated tampon
Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC
Application No.: 10/335759 Filing Date: 31/Dec/2002
Abstract:
A tampon adapted to deliver a therapeutic agent, the tampon including a tampon body having a distal end
and a dosage form affixed to the distal end of the tampon body, wherein the dosage form includes a formulation including a therapeutic agent, and wherein the dosage form comprises a plurality of layers. Also, a method for manufacturing a medicated tampon adapted to deliver a therapeutic agent, the method including manufacturing a tampon body having a distal end
producing a dosage form having a plurality of layers, wherein the dosage form includes a formulation including a therapeutic agent
and affixing the dosage form to the distal end of the tampon body.
Priority: US2000-626025 Applic. Date: 2000-07-27; US1998-079897 Applic. Date: 1998-05-15; US20020347719P Applic. Date: 2002-01-10; US19970049325P Applic. Date: 1997-06-11
Inventor: GEHLING STEVEN CRAIG [US]; HARRISON DONALD C [US]; LIU JAMES H [US]; RITSCHEL WOLFGANG A [US]; CLENDENING CHRIS [US]; PAULETTI GIOVANNI M [US]
Patent No.: US7347872B2 Issued: 25/Mar/2008Title: Connective tissue substitutes, method of preparation and uses thereof
Applicant/Assignee: UNIVERSITE LAVAL UNIVERSITE DE MONTREAL
Application No.: 10/678167 Filing Date: 06/Oct/2003
Abstract:
The present invention relates to connective tissue substitute implant and method of preparation thereof. The implant is essentially composed of two bone anchors joined at the proximal ends by matrix layers and/or filaments coated by supplementary biocompatible matrix coating layer which can contain living stem cells isolated from injured connective tissue.
Priority: US2001-990320 Applic. Date: 2001-11-23; US20000252588P Applic. Date: 2000-11-24
Inventor: GOULET FRANCINE [CA]; RANCOURT DENIS [CA]; CLOUTIER REJEAN [CA]; TREMBLAY JULIE [CA]; AUGER FRANCOIS A [CA]; GUILLEMETTE LEGAL REPRESENTATI [CA]; GERMAIN LUCIE [CA]; LAMONTAGNE JEAN [CA]; BOUCHARD MARC [CA]; LANGELIER EVE [CA]; DUPUIS DANIEL [CA]; BOUCHARD STEPHANE [CA]; ISLAM NAZRUL [CA]; STEVENS LOUIS-MATHIEU [CA]; LAVERTY SHEILA [CA]; LUSSIER BERTRAND [CA]; BELZIL ANNE-MARIE [CA]; TREMBLAY PIERROT [CA]
Patent No.: US7347990B2 Issued: 25/Mar/2008Title: Stick compositions
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC
Application No.: 10/842094 Filing Date: 10/May/2004
Abstract:
Many cosmetic stick compositions containing a continuous phase of a water-immiscible cosmetic oil structured by a fibre-forming amido structurant and an active cosmetic ingredient either exhibit poor physical stability when formed, or cannot be made readily using conventional processes for making stick compositions. The problem can be ameliorated or overcome by the use of a combination of amido structurants comprising in class (i) an N-acylaminoacid amide in which the N-acyl substituent has the formula -CO-Rin which Rrepresents a branched C6 to C11 alkyl group in combination with a further amido structurant, (class (ii), including a polyamido-substituted cyclohexane, an amido derivative of di or tricarboxylic acids or an hydroxystearamide and particularly employing an N-acylaminoacid amide in which the N-acyl substituent contains a linear alkyl group, or a cyclodipeptide.
Priority: GB20030010767 Applic. Date: 2003-05-10
Inventor: EMSLIE BRUCE STEVEN [GB]; FRANKLIN KEVIN RONALD [GB]; CROPPER MARTIN PETER [GB]
Patent No.: US7347991B2 Issued: 25/Mar/2008Title: Stick compositions
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC
Application No.: 10/842136 Filing Date: 10/May/2004
Abstract:
Anhydrous cosmetic stick compositions containing a continuous phase of a water-immiscible cosmetic oil structured by a fibre-forming amido structurant and containing a suspended particulate antiperspirant or deodorant can suffer from either somewhat poor physical stability when formed, or preparative difficulties using conventional processes for making stick compositions or opaqueness. The problem can be ameliorated or overcome by the use of a combination of amido structurants comprising (i) an N-acylaminoacid amide in which the N-acyl substituent has the formula -CO-Rin which Rrepresents a branched C6 to C11 alkyl group in combination with a further amido structurant (ii), selected from (iia) N-acylaminoacid amides other than (i), (iib) cyclodipeptides and (iic) a 1,2-di amido-substituted cyclohexane.
Priority: GB20030010769 Applic. Date: 2003-05-10
Inventor: EMSLIE BRUCE STEVEN [GB]; FRANKLIN KEVIN RONALD [GB]; FLETCHER NEIL ROBERT [GB]
Patent No.: US7347992B2 Issued: 25/Mar/2008Title: Stick compositions
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONPCO, INC
Application No.: 10/842137 Filing Date: 10/May/2004
Abstract:
Anhydrous cosmetic antiperspirant stick compositions containing a continuous phase of a water-immiscible cosmetic oil structured by a fibre-forming amido structurant can exhibit undesirable sensory properties when 12-hydroxy-stearic acid is employed as primary gellant and the preparation of sick compositions suffers from sever processing difficulties when certain of such amido structurants are employed as primary gellant.
Stick compositions having desirable sensory properties can be made by employing as primary gellant, a combination of amido structurants comprising (i) an N-acylaminoacid amide in which the N-acyl substituent has the formula -CO-Rin which Rrepresents a branched C6 to C11 alkyl group and (ii) an N-acylaminoacid amide in which the N-acyl substituent contains a linear alkyl group and the cosmetic carrier oil comprising from 25 to 50% by weight of a water-immiscible monohydric alcohol that is liquid at 20 DEG C. and a boiling point of higher than 100 DEG C.
Priority: GB20030010771 Applic. Date: 2003-05-10
Inventor: FRANKLIN KEVIN RONALD [GB]; WILLIAMS JASON RICHARD [GB]
Patent No.: US7348017B2 Issued: 25/Mar/2008Title: Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
Applicant/Assignee: SHISEIDO CO., LTD
Application No.: 10/487411 Filing Date: 23/Feb/2004
Abstract:
A dithiazole compound or a salt thereof is disclosed. The compound inhibits matrix metalloprotease (MMPs) activity and can be used in pharmaceutical and cosmetic compositions for the treatment of skin conditions.
Priority: JP20010258066 Applic. Date: 2001-08-28; WO2002JP08649 Applic. Date: 2002-08-28
Inventor: HIRUMA TAKUYA [JP]; KOBAYASHI KOJI [JP]; INOMATA SHINJI [JP]
Patent No.: US7351308B2 Issued: 01/Apr/2008Title: Paper products having a tropical composition applied in discrete droplets
Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC
Application No.: 11/367194 Filing Date: 03/Mar/2006
Abstract:
A method is disclosed for application of compositions onto non-woven webs, such as paper webs. The present invention is also directed to products made from the process. In general, the method includes applying a composition to a non-woven web using a non-impact printer, such as an ink jet printer. The composition is applied, in one embodiment, as droplets that remain as discrete shapes on the substrate. In this manner, treated areas and untreated areas are formed on the web. Through this process, the water absorption and control properties of the web can be adjusted as desired while simultaneously treating the web with a composition that improves the physical and/or chemical properties of the web.
Priority: US2002-335138 Applic. Date: 2002-12-31
Inventor: URLAUB JOHN J [US]; SHANNON THOMAS G [US]
Patent No.: US7351745B2 Issued: 01/Apr/2008Title: Compositions and methods of their use for improving the condition and appearance of skin
Applicant/Assignee: AVON PRODUCTS, INC
Application No.: 11/021242 Filing Date: 22/Dec/2004
Abstract:
The present invention relates to compositions and methods for treating, preventing and improving the condition and/or aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include active agents which increase expression levels of genes associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and/or aesthetic appearance of skin.
Priority:
Inventor: DRYER LAURENCE [US]; PTCHELINTSEV DMITRI [US]
Patent No.: US7354571B2 Issued: 08/Apr/2008Title: Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function
Applicant/Assignee: L'OREAL
Application No.: 11/189975 Filing Date: 27/Jul/2005
Abstract:
Unique photoprotective compositions contain novel methyltrialkylsilanes bearing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function, useful as sunscreens that are active in the field of UV radiation.
Priority: FR20030000909 Applic. Date: 2003-01-28; WO2003EP15038 Applic. Date: 2003-12-19; US20030450708P Applic. Date: 2003-03-03
Inventor: RICHARD HERVE [FR]
Patent No.: US7354610B2 Issued: 08/Apr/2008Title: Pharmaceutical and cosmetic composition against skin aging
Applicant/Assignee: INDENA S.P.A
Application No.: 11/783331 Filing Date: 09/Apr/2007
Abstract:
Pharmaceutical and cosmetic compositions for the prevention of skin aging, containing phospholipid complexes of extracts of Vitis vinifera, and phospholipid complexes of standardized extract from Centella asiatica.
Priority: IT2001MI01022 Applic. Date: 2001-05-17; US2003-477703 Applic. Date: 2003-11-14; WO2002EP05147 Applic. Date: 2002-05-10
Inventor: DI PIERRO FRANCESCO [IT]
Patent No.: US7355055B2 Issued: 08/Apr/2008Title: Compounds for treatment of lipase-mediated diseases
Applicant/Assignee: RELIANCE LIFE SCIENCES PVT. LTD
Application No.: 11/222901 Filing Date: 08/Sep/2005
Abstract:
Novel benzoquinone-derived compounds and polymorphs, prodrugs, geometric or optical isomers thereof, and pharmaceutically acceptable esters, ethers, carbamates, oximes of such compounds, polymorphs, prodrugs and isomers are provided. Process for preparation of compounds of the invention and pharmaceutical compositions containing such compounds and their use for reducing or inhibiting activity of lipase gene family for treatment, amelioration or prevention of lipase gene family mediated diseases and conditions including overweight, obesity, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, pancreatitis, diabetes, atherosclerosis, other cardiovascular diseases, metabolic syndromes, and metabolic disorders are provided. Methods of use of the compounds for skin care, hair care and cosmetics are provided.
Priority:
Inventor: UPADHYAY SHAKTI [IN]; YADAV RAMAN [IN]; GANGAN VIJAY [IN]; KANEKAR YOGESH [IN]
Patent No.: US7357919B2 Issued: 15/Apr/2008Title: Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s)
Applicant/Assignee: L'OREAL
Application No.: 11/249304 Filing Date: 14/Oct/2005
Abstract:
Topically applicable, improvedly photostabilized, photoprotective cosmetic/dermatological compositions contain (i) an effective UV-screening amount of at least one dibenzoylmethane sunscreen and an effective photostabilizing amount of (ii) at least one arylalkyl benzoate compound and (iii) at least one compound accepting the excited triplet level energy of said at least one dibenzoylmethane sunscreen, formulated into (iv) a topically applicable, cosmetically/dermatologically acceptable support therefor.
Priority: FR20040052370 Applic. Date: 2004-10-19; US20040623038P Applic. Date: 2004-10-29
Inventor: CANDAU DIDIER [FR]
Patent No.: US7357920B2 Issued: 15/Apr/2008Title: Photostable photoprotective compositions comprising dibenzoylmethane and amide oil compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s)
Applicant/Assignee: L'OREAL
Application No.: 11/249398 Filing Date: 14/Oct/2005
Abstract:
Topically applicable, improvedly photostabilized, photoprotective cosmetic/dermatological compositions contain (i) an effective UV-screening amount of at least one dibenzoylmethane sunscreen and an effective photostabilizing amount of (ii) at least one oil containing at least one amide structural unit and (iii) at least one compound accepting the excited triplet level energy of said at least one dibenzoylmethane sunscreen, formulated into (iv) a topically applicable, cosmetically/dermatologically acceptable support therefor.
Priority: FR20040052367 Applic. Date: 2004-10-19; US20040623034P Applic. Date: 2004-10-29
Inventor: CANDAU DIDIER [FR]
Patent No.: US7358278B2 Issued: 15/Apr/2008Title: Cellular phosphorylation potential enhancing compositions preparation and use thereof
Applicant/Assignee:
Application No.: 10/643080 Filing Date: 19/Aug/2003
Abstract:
A pharmaceutical composition comprising as an active phosphorylation potential enhancing substance a pharmaceutically-acceptable salt of an alpha-keto carboxylic acid thereof alone or in combination with nicatinamide and creatine and, its use and products containing the same.
Priority: US2001-828589 Applic. Date: 2001-04-09; US2000-550047 Applic. Date: 2000-04-14; US1997-999767 Applic. Date: 1997-10-27; US1996-643284 Applic. Date: 1996-05-08; US1996-646572 Applic. Date: 1996-05-08; US1994-239635 Applic. Date: 1994-05-09
Inventor: BUNGER ROLF [US]; VERMA AJAY [US]
Patent No.: US7364565B2 Issued: 29/Apr/2008Title: Controlled enzymatic removal and retrieval of cells
Applicant/Assignee: RAMOT AT TEL AVIV UNIVERSITY LTD
Application No.: 10/768749 Filing Date: 27/Jan/2004
Abstract:
Method and device, including a uniquely operative applicator, and pharmaceutical compositions, for the controlled, non-surgical removal and retrieval of cells from a variety of skin lesions and tissue surfaces are disclosed. A synergistic effect of proteolytic digestion of the intracellular matrix and "stripping" flow is achieved by treating a defined area with a controlled, continuous stream of proteolytic enzyme solution, causing gentle but effective tissue erosion. Isolated cells from the skin lesion and/or tissue surface may be collected from the protease solution stream for histological analysis and/or cell culture, affording a method of "enzymatic biopsy".
The protease solution may be supplemented with anesthetics, coagulants, anticoagulants and antibiotics to decrease the discomfort, erythema, bleeding, risk of infection and scarring traditionally associated with surgical treatment of skin lesions. Delivery of precise levels of catalytic activity is ensured by controlled activation of stable, inactivated enzyme stock solutions and powders shortly prior to application.
Priority: WO2002IL00572 Applic. Date: 2002-07-16; US2001-915518 Applic. Date: 2001-07-27
Inventor: FREEMAN AMIHAY [IL]
Patent No.: US7364720B2 Issued: 29/Apr/2008Title: Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate compounds/amide-based oils and photoprotective compositions comprised thereof
Applicant/Assignee: L'OREAL
Application No.: 11/172902 Filing Date: 05/Jul/2005
Abstract:
The present invention relates to a process for photostabilizing, with respect to UV radiation, at least one dibenzoylmethane derivative with at least one arylalkyl benzoate derivative and at least one oil containing in its structure at least one amide unit. Another subject of the invention also relates to a novel cosmetic or dermatological composition for topical use, characterized in that it comprises, in a cosmetically acceptable support: (a) at least one UV-screening agent of the dibenzoylmethane derivative type and (b) at least one arylalkyl benzoate derivative and (c) at least one oil containing in its structure at least one amide unit.
The present invention also relates to the use of an arylalkyl benzoate derivative and an oil containing in its structure at least one amide unit in a cosmetic or dermatological composition comprising at least one dibenzoylmethane derivative, for the purpose of improving the stability with respect to UV rays of the said dibenzoylmethane derivative.
Priority: FR20040051417 Applic. Date: 2004-07-02; US20040589010P Applic. Date: 2004-07-20
Inventor: CANDAU DIDIER [FR]
Patent No.: US7364721B2 Issued: 29/Apr/2008Title: Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate compounds and photoprotective cosmetic compositions comprised thereof
Applicant/Assignee: L'OREAL
Application No.: 11/172949 Filing Date: 05/Jul/2005
Abstract:
Topically applicable cosmetic/dermatological photoprotective compositions contain at least one dibenzoylmethane UV-screening agent, and, as a photostabilizer therefor, at least one arylalkyl benzoate compound of formula (I) or (II) below: with the proviso that: (i) the subject compositions are characteristically devoid of any octyl methoxycinnamate
and (ii) same are other than a solution of butyl methoxydibenzoylmethane in 2-phenylethyl benzoate, 2-phenylethyl o-toluate, 2-phenylethyl p-toluate or in a 2-phenylethyl o-toluate/2-phenylethyl p-toluate (1/1) mixture.
Priority: FR20040051416 Applic. Date: 2004-07-02; US20040588984P Applic. Date: 2004-07-20
Inventor: CANDAU DIDIER [FR]
Patent No.: US7364722B2 Issued: 29/Apr/2008Title: Pharmaceutical and cosmetic compositions comprising plgf-1
Applicant/Assignee: GEYMONAT S.P.A
Application No.: 10/507272 Filing Date: 22/Nov/2004
Abstract:
The invention relates to the preparation of placental growth factor (PLGF)-comprising therapeutic and cosmetic compositions capable of increasing angiogenesis of the cutaneous, subcutaneous and internal organ connective tissue. Such compositions are suitable for the treatment of pathological or natural states benefiting from the formation or regeneration of new vessels of the cutaneous compartment, such as scleroderma, its various manifestations, skin aging or loss of hair.
Priority: IT2002RM00119 Applic. Date: 2002-03-05; WO2003IT00132 Applic. Date: 2003-03-05
Inventor: MAGLIONE DOMENICO [IT]; BATTISTI MAURO [IT]; CONTI ETTORE [IT]; SALVIA GIUSEPPE [IT]; TUCCI MARINA [IT]
Patent No.: US7367341B2 Issued: 06/May/2008Title: Methods and devices for selective disruption of fatty tissue by controlled cooling
Applicant/Assignee: THE GENERAL HOSPITAL CORPORATION
Application No.: 10/391221 Filing Date: 17/Mar/2003
Abstract:
The present invention relates to methods for use in the selective disruption of lipid-rich cells by controlled cooling. The present invention further relates to a device for use in carrying out the methods for selective disruption of lipid-rich cells by controlled cooling.
Priority: US20020365662P Applic. Date: 2002-03-15
Inventor: ANDERSON RICHARD ROX [US]; MANSTEIN DIETER [US]
Patent No.: US7368105B2 Issued: 06/May/2008Title: Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate/bis-resorcinyl triazine compounds and photoprotective compositions comprised thereof
Applicant/Assignee: L'OREAL
Application No.: 11/172932 Filing Date: 05/Jul/2005
Abstract:
Topically applicable, photostable compositions with respect to UV radiation contain at least one dibenzoylmethane UV-screening agent and at least one arylalkyl benzoate compound and at least one bis-resorcinyl triazine compound.
Priority: FR20040051419 Applic. Date: 2004-07-02; US20040589009P Applic. Date: 2004-07-20
Inventor: CANDAU DIDIER [FR]
Patent No.: US7368122B1 Issued: 06/May/2008Title: Skin cream
Applicant/Assignee: DOW PHARMACEUTICAL SCIENCES
Application No.: 10/094534 Filing Date: 08/Mar/2002
Abstract:
An emulsion for topical application to the skin containing a high molecular weight emulsifier and substantially no emulsifiers of a molecular weight less than 100 kD. The emulsion may be used to prevent or treat dermatoses and may additionally contain pharmaceutically active ingredients.
Priority:
Inventor: DOW GORDON J [US]; BEAN KEVIN [US]
Patent No.: US7371396B2 Issued: 13/May/2008Title: Dermatological and cosmetic compositions
Applicant/Assignee: RELIVIA SRL
Application No.: 10/477707 Filing Date: 13/Feb/2004
Abstract:
The present invention relates to a dermatological and/or cosmetic composition comprising a furfuryl derivative of formula (I), and its use in the treatment of dermatological disorders especially when caused by free radicals.
Priority: WO2002IB01653 Applic. Date: 2002-05-15; IT2001MI01019 Applic. Date: 2001-05-17
Inventor: GHISALBERTI CARLO [BR]
Patent No.: US7374771B2 Issued: 20/May/2008Title: Use of siloxanes as vaporizable carriers
Applicant/Assignee: GE BAYER SILICONES GMBH & CO., KG
Application No.: 10/495343 Filing Date: 26/Oct/2004
Abstract:
Cosmetic formulations comprising alkyl-substituted siloxanes as vaporizable carriers.
Priority: DE20011055512 Applic. Date: 2001-11-13; WO2002EP12596 Applic. Date: 2002-11-12
Inventor: EVERSHEIM HUBERTUS [DE]; KROPFGANS MARTIN [DE]; NIENSTEDT SABINE [DE]; LANGE HORST [DE]
Patent No.: US7375085B1 Issued: 20/May/2008Title: Melanocyte-stimulating hormone inhibitors
Applicant/Assignee: AJINOMOTO CO., INC
Application No.: 09/926391 Filing Date: 25/Apr/2000
Abstract:
In the present specification is disclosed a melanocyte-stimulating hormone inhibitory composition which comprises, as the active ingredient, a di- or tripeptide derivative having a certain naphthyl group or the salts thereof, or a melanocyte-stimulating hormone inhibitory compound having a 50% inhibitory concentration of cAMP production (IC50) of 100 nM or less, which composition can prevent pigmentation, or can prevent, improve or recover from immune abnormality or immunodeficiency, or regulate body weight by appetite control, and also can be used as cosmetics or external preparations for the skin, and in addition, can be produced easily, and are excellent in the stability during storage.
Priority: JP19990118633 Applic. Date: 1999-04-26; WO2000JP02687 Applic. Date: 2000-04-25
Inventor: SHIOJIRI EIJI [JP]; TAKINO YOSHINOBU [JP]; CHUJOU HIROMI [JP]; SAKAMOTO KAZUTAMI [JP]; IJICHI CHIORI [JP]; ETO YUZURU [JP]; IWASAKI KEIJI [JP]
Patent No.: US7378083B2 Issued: 27/May/2008Title: Stable cosmetic composition comprising a self-tanning agent
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 10/842585 Filing Date: 10/May/2004
Abstract:
Stable topical compositions having a pH of from 3.5 to 4.5 comprising a self-tanning agent, a polymer and a polyhydric alcohol humectant. The compositions of the present invention are highly stable, and deliver high levels of active self-tanning agent to the skin upon topical application.
Priority: EP20030253316 Applic. Date: 2003-05-27
Inventor: STEPHENS ALISON FIONA [GB]; CROOK TERESA BARBARA [GB]
Patent No.: US7378084B2 Issued: 27/May/2008Title: Sunless tanning composition and method of sunless tanning
Applicant/Assignee: PLAYTEX PRODUCTS, INC
Application No.: 11/174044 Filing Date: 01/Jul/2005
Abstract:
A sunless tanning composition having dihydroacetone and an amphoglycinate (amphoacetate) in an amount effective for sunless tanning is provided. Also provided is a method of sunless tanning having the step of topically applying to the skin an effective amount of a sunless tanning composition having dihydroacetone and an amphoglycinate.
Priority:
Inventor: DUEVA-KOGANOV OLGA [US]; RUSSO THOMAS [US]; SANOGUEIRA JAMES P [US]
Patent No.: US7381417B2 Issued: 03/Jun/2008Title: Fragrance delivery system for surface cleaners and conditioners
Applicant/Assignee: FIRMENICH SA
Application No.: 11/408179 Filing Date: 21/Apr/2006
Abstract:
We claim a fragrance delivery system consisting of a mixture of various polymers oligomers and stabilizers capable of forming a surfactant complex gel dispersion when combined with a cleansing surfactant base and yielding high levels of fragrance deposition onto the skin, hair or other surface such as a textile, from a cleansing or softening consumer product comprising a micelle forming surfactant. The internal phase or dispersible phase of this surfactant complex gel dispersion (GLPPD) is made of a mixture of various immiscible polymers, oligomers and stabilizers forming a complex gel with the surfactant platform and whose ratio and composition are selected to dissolve preferentially a wide range of fragrance raw materials.
The selection criteria are, first, that the fragrance should present a higher fragrance partitioning ratio into the surfactant complex gel phase than into the free micelles of the surfactant, second, that the surfactant complex gel should not be further solubilized by the free micelles, and third, that the polymer mixture selected should complex with the surfactant system. The external or dispersing phase of the GLPPD is made of a single cationic polymer or a mixture of cationic polymers that have been hydrated and associated with the surfactant to form a complex gel structure that cannot be further solubilized by the free micelles.
Priority: WO2003IB04867 Applic. Date: 2003-10-31; WO2004IB03544 Applic. Date: 2004-10-28; US20030516548P Applic. Date: 2003-10-31
Inventor: GAMEZ-GARCIA MANUEL [US]
Patent No.: US7381692B2 Issued: 03/Jun/2008Title: Bar soap with fibrous assembly
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE, USA DIVISION OF CONOPCO, INC
Application No.: 11/008528 Filing Date: 09/Dec/2004
Abstract:
A cleansing article composed of a solid or semi-solid foamable composition and a batting layer with bonded fibers is described that provides the user with a pleasant personal cleansing experience and which in one embodiment combines cleansing, aesthetic and/or skin benefit with active agents and exfoliation. The user also experiences substantial lather during use of the cleansing article. The batting layer is at least partially encompassed by the solid or semi-solid foamable composition.
Priority: US20040579592P Applic. Date: 2004-06-14
Inventor: GRISSETT GREGORY AARON [US]; MACEDO FILOMENA AUGUSTA [US]; KEENAN DIANE MARIE [US]; WILLIAMS DAVID ROBERT [US]
Patent No.: US7381693B2 Issued: 03/Jun/2008Title: Fibrous elastic gel cleansing article
Applicant/Assignee: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC UNILEVER HOME & PERSONAL CARE USA, DIVISON OF CONOPCO, INC
Application No.: 11/023207 Filing Date: 27/Dec/2004
Abstract:
An article that is especially suitable for cleansing skin is described which includes a foamable composition having the form of an elastic semi-solid gel and a fibrous layer made up of a continuous network of bonded fibers. The weight ratio of the foamable composition to the fibrous layer is in the range from about 30 to 1 to about 2000 to 1 and the foamable composition at least partially encompasses the fibrous layer.
Priority: US20040579592P Applic. Date: 2004-06-14
Inventor: KEENAN DIANE MARIE [US]; GRISSETT GREGORY AARON [US]; MACEDO FILOMENA AUGUSTA [US]; WILLIAMS DAVID ROBERT [US]
Patent No.: US7387788B1 Issued: 17/Jun/2008Title: Pharmaceutical compositions of nicotine and methods of use thereof
Applicant/Assignee: ANTARES PHARMA IPL AG
Application No.: 11/492568 Filing Date: 24/Jul/2006
Abstract:
The present invention comprises non occlusive compositions for transdermal delivery of nicotine, and more particularly pharmaceutically acceptable salts thereof, and methods of making same. The composition may, for example, be a gel suitable for transdermal or transmucosal applications. The compositions of the present invention typically comprise a mixture of water and alcohol, and a solvent system having a mono alkyl ether of diethylene glycol and a glycol present in specified ratios and in specific amounts, wherein the pH of the gel is usually between a pH of 5.5 and 7. The compositions may include further components, for example, the hydroalcoholic vehicle may further comprise additional penetration enhancer(s), buffering agent(s), antioxidant(s), stabilizer(s) and/or gelling agent(s). The invention also relates to a method for the sustained delivery of nicotine pharmaceutically acceptable salts to treat a variety of conditions and disorders.
Priority: US2006-371042 Applic. Date: 2006-03-07; WO2004EP11175 Applic. Date: 2004-10-06; US20030510613P Applic. Date: 2003-10-10
Inventor: CARRARA R DARIO NORBERTO [CH]; GRENIER ARNAUD [FR]; BESSE CELINE [FR]
Patent No.: US7388029B2 Issued: 17/Jun/2008Title: Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
Applicant/Assignee: DUKE UNIVERSITY
Application No.: 11/138097 Filing Date: 26/May/2005
Abstract:
A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
Priority: US2001-774557 Applic. Date: 2001-01-31; US20000193645P Applic. Date: 2000-03-31
Inventor: DELONG MITCHELL ANTHONY [US]; MCIVER JOHN MCMILLAN [US]; YOUNGQUIST ROBERT SCOTT [US]
Patent No.: US7388105B2 Issued: 17/Jun/2008Title: Compounds and use to reduce the formation of malodour
Applicant/Assignee: GIVAUDAN S.A
Application No.: 11/584686 Filing Date: 20/Oct/2006
Abstract:
Malodour formation reducing compounds alpha-N-(3-Methyl-5-phenylpentanoxycarbonyl)-L-glutamine, alpha-N-(2-Methyl-5-phenylpentanoxycarbonyl)-L-glutamine, and alpha-N-(2,4-Dimethyl-4-phenylbutanoxycarbonyl)-L-glutamine, and their salts, compositions comprising such compounds, including cosmetic products, personal care products, and deodorant products, and methods forming such products and their use. The compounds are useful to reduce the formation of human malodour resulting from bacterial degradation of compounds naturally present in sweat, in particular axilliary malodour.
Priority: US20050729285P Applic. Date: 2005-10-21
Inventor: NATSCH ANDREAS [CH]; FLACHSMANN FELIX [CH]
Patent No.: US7390507B2 Issued: 24/Jun/2008Title: Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
Applicant/Assignee:
Application No.: 10/823175 Filing Date: 13/Apr/2004
Abstract:
The present invention relates to compositions and methods for the treatment of traumatic conditions of the skin including radiation dermatitis, thermal burn, sunburn, dermatomyo-fibromas, and exposure-induced wrinkles, comprising omega-3 fish oils, tocopherols, lavender oil and a suitable amount of a pharmaceutically acceptable carrier, and optionally, one or more of the following: Sodium PCA, or MSM.
Priority:
Inventor: RUWART MARY J [US]
Patent No.: US7392204B1 Issued: 24/Jun/2008Title: Method for selecting cosmetics
Applicant/Assignee: SHISEIDO CO., LTD
Application No.: 09/666184 Filing Date: 21/Sep/2000
Abstract:
An average face composition is produced by computer graphic methods surveying average facial features, skin color, lip color and eye color among plural faces representing different human races. Enquiries are performed among a plurality of different people to receive their replies to questions on the obtained faces on which various cosmetics were furnished. The collected comments were analyzed to prepare color maps, whereby necessary information and images were established to enable selection of suitable cosmetics.
Priority: JP19990281596 Applic. Date: 1999-10-01
Inventor: MATSUMOTO KYOKO [JP]; TAKEDA TAKESHI [JP]; GOTO YASUO [JP]
Patent No.: US7396526B1 Issued: 08/Jul/2008Title: Skin care composition
Applicant/Assignee: JOHNSON & JOHNSON CONSUMER COMPANIES, INC
Application No.: 09/565716 Filing Date: 05/May/2000
Abstract:
There are provided compositions which include a retinoid and preferably retinal
a dermatologically active acid
and a volatile base, such as ammonium hydroxide. Another embodiment of the invention includes compositions comprising a retinoid and preferably retinal
a dermatologically active acid
a volatile base
and a second neutralizing agent. There are also provided compositions which include a retinoid, a neutralized ammonium salt of a dermatologically active acid, and optionally a neutralized salt, other than ammonium salt, of an acid. Further provided are methods for reducing fine lines, wrinkles, skin roughness, and pore size and for increasing the clarity of a skin surface, cellular turnover, skin radiance, skin smoothness, skin permeation or collagen synthesis in a mammal in need thereof. Compositions as described above are administered topically to the skin of the animal.
Priority: US1999-436867 Applic. Date: 1999-11-09; US19980107956P Applic. Date: 1998-11-12
Inventor: COLE CURTIS A [US]; FLACK LAURA E [US]; KAMINSKI CLAUDIA [US]; VAN LEEUWEN VICTORIA [FR]; LUKENBACH ELVIN R [US]
Patent No.: US7404946B2 Issued: 29/Jul/2008Title: Antiperspirant methods and compositions
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY THE PROCTER AND GAMBLE COMPANY
Application No.: 10/719755 Filing Date: 21/Nov/2003
Abstract:
An antiperspirant compositions and corresponding methods of application wherein the compositions comprise a) a skin-adhering system comprising i) a skin-adhering polymer, ii) one or more volatile solvents
b) antiperspirant active
c) thickening agent
and d) an anhydrous carrier in an amount sufficient to provide enhanced substantivity of antiperspirant actives.
Priority:
Inventor: BOWENS-JONES ANDREA DEMETRIUS [US]; ALLEN ANTOINETTE LYNN [US]
Patent No.: US7404966B2 Issued: 29/Jul/2008Title: Transfer-resistant makeup removing compositions
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 09/902048 Filing Date: 10/Jul/2001
Abstract:
The invention relates to a cleansing composition suitable for topical application to human skin, more particularly to an oil-based cleansing composition containing a silicone elastomer gelling agent for removal of make-up from the skin.
Priority: US20000217120P Applic. Date: 2000-07-10; US20000217872P Applic. Date: 2000-07-12
Inventor: VATTER MICHAEL LEE [US]
Patent No.: US7404967B2 Issued: 29/Jul/2008Title: Topical product formulations containing strontium for reducing skin irritation
Applicant/Assignee: COSMEDERM TECHNOLOGIES, LLC COSMEDERM, INC
Application No.: 09/992491 Filing Date: 21/Nov/2001
Abstract:
Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical formulation vehicle, and methods of using these formulations to inhibit skin irritation, are disclosed.
Priority: US2001-871576 Applic. Date: 2001-05-31; US1998-149886 Applic. Date: 1998-09-08; US1996-666978 Applic. Date: 1996-06-20; US1994-362100 Applic. Date: 1994-12-21
Inventor: HAHN GARY S [US]; THUESON DAVID O [US]
Patent No.: US7407987B2 Issued: 05/Aug/2008Title: Compositions and Methods for Treating Hair Loss Using C16-C20 Aromatic Tetrahydro Prostaglandins
Applicant/Assignee: DUKE UNIVERSITY
Application No.: 11/565297 Filing Date: 30/Nov/2006
Abstract:
A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
Priority: US2001-774555 Applic. Date: 2001-01-31; US20000193846P Applic. Date: 2000-03-31
Inventor: DELONG MITCHELL ANTHONY [US]; MCIVER JOHN MCMILLAN [US]; YOUNGQUIST ROBERT SCOTT [US]
Patent No.: US7409242B2 Issued: 05/Aug/2008Title: Active muscle display device
Applicant/Assignee: NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
Application No.: 10/527087 Filing Date: 14/Nov/2005
Abstract:
In order to provide an active muscle display unit that extracts a firing pattern of the individual motor unit without applying a load to living organisms and display the extracted motor unit, the active muscle display unit comprises multiple electrodes that are arranged on a skin surface, a surface electromyogram measuring part that measures a surface electromyogram on the skin surface at the multiple electrodes, a motor unit separating part that estimates the individual motor unit constituting an active muscle based on the surface electromyogram measured by the surface electromyogram measuring part, a motor unit position estimating part that estimates a three-dimensional position of the firing motor unit based on the motor unit estimated to be the firing motor unit by the motor unit separating part,
and a display part that displays the motor unit estimated by the motor unit position estimating part in an image.
Priority: WO2002JP09302 Applic. Date: 2002-09-11
Inventor: MAEKAWA SATOSHI [JP]; FUJIWARA YOSHIHISA [JP]; KOTANI LEGAL REPRESENTATIVE HI [JP]; ARIMOTO TAKAHIKO [JP]
Patent No.: US7413747B2 Issued: 19/Aug/2008Title: TRANSDERMAL THERAPEUTIC SYSTEM FOR TREATING PARKINSONISM
Applicant/Assignee: LTS LOHMANN THERAPIE-SYSTEME AG SCHWARZ PHARMA LIMITED
Application No.: 11/931666 Filing Date: 31/Oct/2007
Abstract:
A transdermal therapeutic system (TTS) comprises a silicone-based polymer adhesive system having distributed therein (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol free base in an amount of about 5% to 40% by weight. The adhesive system comprises a silicone adhesive and an additive having increased solubility for the active substance, in an amount effective to increase dissolving capacity of the matrix for the active substance.
Priority: DE19981014084 Applic. Date: 1998-03-30; US2004-936620 Applic. Date: 2004-09-07; US2000-647290 Applic. Date: 2000-11-28; WO1999EP01795 Applic. Date: 1999-03-18
Inventor: MUELLER WALTER [DE]; PECK JAMES V [US]
Patent No.: US7413755B2 Issued: 19/Aug/2008Title: Use of a cotton honeydew extract as active ingredient in or for preparing a cosmetic and/or pharmaceutical composition
Applicant/Assignee: SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS S.A
Application No.: 10/537359 Filing Date: 03/Jun/2005
Abstract:
The invention concerns the use, as active principle, in or for preparing a composition, of an efficient amount of at least one extract of cotton honeydew, the extract or the composition being designed for care of keratinous substrates. The invention also concerns a cosmetic and/or pharmaceutical composition containing said extract, and a method for cosmetic treatment of the skin using said cotton honeydew extract or the composition containing same.
Priority: FR20020015189 Applic. Date: 2002-12-03; WO2003FR03557 Applic. Date: 2003-12-02
Inventor: DAL FARRA CLAUDE [FR]; DOMLOGE NOUHA [FR]; PEYRONEL DOMINIQUE [FR]
Patent No.: US7417014B2 Issued: 26/Aug/2008Title: DILUTION THICKENED PERSONAL CLEANSING COMPOSITION
Applicant/Assignee: CONOPCO, INC., D/B/A UNILEVER CONOPCO, INC
Application No.: 11/423787 Filing Date: 13/Jun/2006
Abstract:
A liquid or flowable cleansing composition is described that contains high levels of anionic and nonionic surfactants and that show a substantial increase in viscosity upon dilution with water. The cleansing composition also contains water soluble EO/PO block copolymer(s).
Priority:
Inventor: MOADDEL TEANOOSH [US]; ABBAS SYED HUSAIN [US]; OZKAN-BAL KIMBERLY [US]
Patent No.: US7419663B2 Issued: 02/Sep/2008Title: Treatment of complement-associated disorders
Applicant/Assignee: GENENTECH, INC
Application No.: 10/964263 Filing Date: 12/Oct/2004
Abstract:
The present invention concerns a recently discovered macrophage specific receptor, STIgMA, and its use in the treatment of complement-associated disorders.
Priority: WO1998US19437 Applic. Date: 1998-09-17; US2004-767374 Applic. Date: 2004-01-29; US2004-767904 Applic. Date: 2004-01-29; US2001-953499 Applic. Date: 2001-09-14; WO2003US31207 Applic. Date: 2003-10-01; US2003-633008 Applic. Date: 2003-07-31; US2002-265542 Applic. Date: 2002-10-03; US1999-380138 Applic. Date: 1999-08-25; WO1999US05028 Applic. Date: 1999-03-08; US1999-254465 Applic. Date: 1999-03-05; WO1998US24855 Applic. Date: 1998-11-20; US19980078936P Applic. Date: 1998-03-20
Inventor: ASHKENAZI AVI [US]; HELMY KARIM YUSSEF [US]; FONG SHERMAN [US]; GODDARD AUDREY [US]; GURNEY AUSTIN L [US]; KATSCHKE JR KENNETH JAMES [US]; NAPIER MARY A [US]; TUMAS DANIEL [US]; VAN LOOKEREN MENNO [US]; WOOD WILLIAM I [US]
Patent No.: US7419677B2 Issued: 02/Sep/2008Title: Treatment device and method of using the same
Applicant/Assignee: L'OREAL L'OREAL S.A
Application No.: 10/107410 Filing Date: 28/Mar/2002
Abstract:
A treatment device may comprise a cover defining a cavity, wherein the cavity is configured to receive a part of a body. The cover may comprise at least one sheet having a composite structure. The composite structure may comprise at least two layers and at least one adhesive matrix situated between the two layers. At least one of the two layers may be permeable to a solvent, and the two layers may be permanently bonded to the adhesive matrix. The adhesive matrix may contain at least one active agent that is soluble in the solvent. When the active agent is dissolved in the solvent, the active agent may be released from at least one side of the cover.
Priority: FR20010004169 Applic. Date: 2001-03-28
Inventor: GUERET JEAN-LOUIS H [FR]
Patent No.: US7419958B2 Issued: 02/Sep/2008Title: Method of attenuating reactions to skin irritants
Applicant/Assignee: DANA-FARBER CANCER INSTITUTE, INC
Application No.: 10/106901 Filing Date: 26/Mar/2002
Abstract:
The present invention is directed to a method of inhibiting CD1d activation by administering a composition containing a moiety that blocks CD1d activation. Compositions of the invention are useful for the attenuation of CD1d-restricted immune responses, including treatment of skin disorders due to hyperactive immune responses (e.g., contact hypersensitivity), for systemic administration to attenuate ongoing immune responses, and to provide hypoallergenic cosmetic products including pharmaceutical, cosmetic, and skin care compositions. Preferably, these compositions are in a form intended for topical administration.
Priority: US20010278837P Applic. Date: 2001-03-26
Inventor: WILSON S BRIAN [US]; DRANOFF GLENN [US]; GILLESSEN SILKE [CH]
Patent No.: US7423082B2 Issued: 09/Sep/2008Title: Associative thickeners for aqueous systems
Applicant/Assignee: LUBRIZOL ADVANCED MATERIALS, INC
Application No.: 11/206393 Filing Date: 18/Aug/2005
Abstract:
Thiocarbonate compounds which, in one embodiment, are utilized as a rheology modifier or associative thickener. The thiocarbonate compounds thicken or increase the viscosity of a composition, preferably an aqueous composition when used in an effective amount. In one preferred embodiment, the thiocarbonate compounds include at least one hydrophilic group containing repeat unit such as derived from acrylic acid, and at least one hydrophobic group to enhance association with other compounds and thus increase viscosity of a composition. Aqueous composition comprising a latex and thiocarbonate associative thickeners are described.
Priority: US20040603448P Applic. Date: 2004-08-20
Inventor: LAI JOHN TA-YUAN [US]; HSU SHUI-JEN RAYMOND [US]; TAMARESELVY KRISHNAN [US]
Patent No.: US7425292B2 Issued: 16/Sep/2008Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
Applicant/Assignee: INTERNATIONAL FLUIDICS MONOSOL RX, LLC
Application No.: 10/074272 Filing Date: 14/Feb/2002
Abstract:
The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film.
Priority: US20010328868P Applic. Date: 2001-10-12
Inventor: YANG ROBERT K [US]; FUISZ RICHARD C [US]; MYERS GARY L [US]; FUISZ JOSEPH M [US]
Patent No.: US7425320B2 Issued: 16/Sep/2008Title: Use of guaiol for treating the skin
Applicant/Assignee: CIBA SPECIALTY CHEMICALS CORP
Application No.: 10/489645 Filing Date: 20/Sep/2004
Abstract:
The use is described of compositions comprising (a) (-)-guaiol, (b) further skin-lightening active substance(s) and, optionally, (c) one or more UV-A and/or UV-B absorbers as melanogenesis inhibitors and for skin-lightening.
Priority: EP20010810902 Applic. Date: 2001-09-18; WO2002EP10163 Applic. Date: 2002-09-10
Inventor: BASCHONG WERNER [CH]; HEINEMANN GERD [DE]; OCHS DIETMAR [DE]
Patent No.: US7425535B2 Issued: 16/Sep/2008Title: Therapeutic pore-forming peptides
Applicant/Assignee: GREENVILLE HOSPITAL SYSTEM GHC RESEARCH DEVELOPMENT CORPORATION
Application No.: 11/123182 Filing Date: 06/May/2005
Abstract:
A class of procytotoxic agents is characterized by a capability to kill with target cell-specificity. Such an aspect can be a pore-forming protein which has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group. These agents are useful in treating cancer, especially prostate cancer.
Priority: US2001-851422 Applic. Date: 2001-05-09; US20000203063P Applic. Date: 2000-05-09; US20000212042P Applic. Date: 2000-06-16
Inventor: YU XIANZHONG [US]; WAGNER THOMAS E [US]
Patent No.: US7425651B2 Issued: 16/Sep/2008Title: Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof
Applicant/Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD
Application No.: 10/581546 Filing Date: 01/Dec/2004
Abstract:
The present invention provides novel jasmonate derivative compounds, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for treatment of cancers, especially mammalian cancers.
Priority: US20030526081P Applic. Date: 2003-12-02; WO2004IL01098 Applic. Date: 2004-12-01
Inventor: FLESCHER ELIEZER [IL]; KASHMAN YOEL [IL]; REISCHER DORIT [IL]; SHIMONY SHIRI [IL]
Patent No.: US7427289B2 Issued: 23/Sep/2008Title: Multiple wavelength laser workstation
Applicant/Assignee: CYNOSURE, INC
Application No.: 11/035680 Filing Date: 14/Jan/2005
Abstract:
Lasers capable of lasing at at least two wavelengths are provided having a lasing medium which is capable of lasing at a first wavelength and at a second wavelength. Also disclosed are laser workstations having two lasers driven by a single electronics drive system in which a single energy storage network is connected to a first laser pump chamber operative to excite a first laser medium and connected to a second laser pump chamber operative to excite a second laser medium.
Priority:
Inventor: SIERRA RAFAEL ARMANDO [US]; KOSCHMANN ERIC CALVIN [US]; DAY JOSEPH M [US]; SHERR EVAN ANDREW [US]; BOLL JAMES HENRY [US]
Patent No.: US7427407B2 Issued: 23/Sep/2008Title: Cosmetics
Applicant/Assignee: KAO CORPORATION
Application No.: 10/468393 Filing Date: 28/Aug/2003
Abstract:
Cosmetics containing the following components (A) and (B): (A) an oil-absorbing powder having a squalane-absorbing ability of 1 ml/g or more
and (B) a compound having an affinity for component (A) lower than that of sebum, and having an ability to absorb the sebum and release component (B) in exchange for the sebum when the cosmetic is applied onto the skin. These cosmetics can adequately absorb the sebum and thus exhibit excellent effects of relieving or preventing oiliness of the skin and worsening in makeup. By selecting an appropriate compound to be released in exchange for the absorbed sebum, a substance capable of improving the skin qualities such as moistness, tightness, and tension can be allowed to penetrate into the skin. Moreover, a bodily feeling of the removal of the sebum can be imparted to users thereby.
Priority: JP20010053843 Applic. Date: 2001-02-28; JP20010184475 Applic. Date: 2001-06-19; WO2002JP01852 Applic. Date: 2002-02-28
Inventor: KUME TAKUJI [JP]; KAWADA HIROMITSU [JP]; JISAI YASUHIRO [JP]; SANO TOMOHIKO [JP]
Patent No.: US7431917B2 Issued: 07/Oct/2008Title: Photostable photoprotective compositions comprising dibenzoylmethane and bis-resorcinyl triazine compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s)
Applicant/Assignee: L'OREAL
Application No.: 11/249521 Filing Date: 14/Oct/2005
Abstract:
Topically applicable, improvedly photostabilized, photoprotective cosmetic/dermatological compositions contain (i) an effective UV-screening amount of at least one dibenzoylmethane sunscreen and an effective photostabilizing amount of (ii) at least one bis-resorcinyl triazine compound and (iii) at least one compound accepting the excited triplet level energy of said at least one dibenzoylmethane sunscreen, notably at least one 4-hydroxybenzylidenemalonate compound, 4-hydroxycinnamate compound, fluorene compound, piperidinol salt, or mixture thereof, formulated into (iv) a topically applicable, cosmetically/dermatologically acceptable support therefor.
Priority: FR20040052368 Applic. Date: 2004-10-19; US20040623580P Applic. Date: 2004-10-29
Inventor: CANDAU DIDIER [FR]
Patent No.: US7438928B2 Issued: 21/Oct/2008Title: Topical gel matrix
Applicant/Assignee: ROLF C. HAGEN, INC
Application No.: 10/685685 Filing Date: 15/Oct/2003
Abstract:
A topical gel matrix that can be used alone or combination with a medication entrapped therein. The gel matrix is dispersible in water. The gel may have the following composition: oil, water or aqueous solution
solvents, surfactants and/or detergents
and a polymer which is a consistence modifier capable of thickening and to resist degradation in a water environment. The matrix may comprise or not a biologically active ingredient for a systemic or topical indication. Amongst preferred medications are anaesthetic, anti-histaminic, anti-inflammatory, anti-oxidant, anti-UVs, anti-microbial and wound healing agents. More specifically, for the treatment of fish infections, examples of preferred active ingredients are natural or synthetic plants extracts.
Priority: US20020418726P Applic. Date: 2002-10-17
Inventor: COSTA ANTHONY [CA]; CHOQUET BENOIT [CA]; GIGUERE YVAN [CA]
Patent No.: US7442682B2 Issued: 28/Oct/2008Title: Transepithelial delivery of peptides with incretin hormone activities
Applicant/Assignee: NITTO DENKO CORPORATION
Application No.: 11/219145 Filing Date: 02/Sep/2005
Abstract:
Compositions and methods are disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially using a transepithelial carrier peptide. The transepithelial peptide contains sufficient amino, guanidine or amidino groups to stimulate transepithelial delivery. In some embodiments, the transepithelial carrier and the peptide with incretin hormone activity are embedded in a pressure sensitive adhesive layer of a plaster or patch.
Priority: US20040620001P Applic. Date: 2004-10-19
Inventor: KITAURA CHIEKO [JP]; MINOMI KENJIRO [JP]; OKUBO KATSUYUKI [JP]; OKADA KEISAKU [JP]; KAGEHISA NATSUKO [JP]; KAMIYAMA MASASHI [JP]; HOU ZHENG [US]; LIU JIAN [US]; SONG YUCHENG [US]; YU LEI [US]
Patent No.: US7446230B2 Issued: 04/Nov/2008Title: Dibenzoylmethane-based compounds, use as photoactivatable sunscreens and cosmetic compositions containing them
Applicant/Assignee: UNIVERSITE PAUL SABATIER TOULOUSE 3 LABORATOIRE BIODERMA CNRS-CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Application No.: 10/564888 Filing Date: 15/Jul/2004
Abstract:
The present invention relates to dibenzoylmethane-based compounds of formula 1, and also to salts or solvates thereof, and to the process for preparing them. The invention also relates to the use of a compound of formula (I) as an agent for protecting the skin or the hair against UV radiation and to a cosmetic and/or dermatological product, characterized in that it comprises a compound of formula (I) as active principle.
Priority: FR20030008736 Applic. Date: 2003-07-17; WO2004FR01859 Applic. Date: 2004-07-15
Inventor: RICO-LATTES ISABELLE [FR]; WETZ FABIENNE [FR]; ROUTABOUL CORINNE [FR]; DENIS ALAIN [FR]
Patent No.: US7448497B2 Issued: 11/Nov/2008Title: Batteries, accessories, marketing bundles and marketing methods
Applicant/Assignee: FCK, LLC
Application No.: 10/748889 Filing Date: 30/Dec/2003
Abstract:
A battery bundle includes a first battery having a first outer surface with a first graphic, a second battery substantially identical to the first battery in all respects except that the second battery has a second outer surface with a second graphic distinct from the first graphic and a packaging binding the first battery and the second battery.
Priority: US20020436976P Applic. Date: 2002-12-30
Inventor: MUCHIN JAY Z [US]; MERTEN DAVID J [US]
Patent No.: US7449307B2 Issued: 11/Nov/2008Title: Raised surface assay plate
Applicant/Assignee: TRANSFORM PHARMACEUTICALS, INC
Application No.: 10/694639 Filing Date: 27/Oct/2003
Abstract:
The assay plate includes a substrate having an substrate surface and at least one raised pad extending from the substrate surface. The raised pad includes a substantially planar sample receiving surface configured for holding a sample thereon for in situ experimentation. The sample receiving surface preferably has at least one sharp edge at the junction between a sidewall coupling the sample receiving surface to the substrate surface. The sample receiving surface is preferably a circle, oval, square, rectangle, triangle, pentagon, hexagon, or octagon shape that is sized to hold a predetermined volume of the sample. A method of using the above described assay plate is also provided. Once a raised pad extending from a substrate is formed, a sample is deposited on the raised pad. Experiments are subsequently performed using the sample on the raised pad.
Priority: US20020428164P Applic. Date: 2002-11-21; US2002-282505 Applic. Date: 2002-10-28; US2003-439943 Applic. Date: 2003-05-16
Inventor: CIMA MICHAEL [US]; LEWIS WENDY PRYCE [US]; GONZALEZ-ZUGASTI JAVIER [US]; GYORY J RICHARD [US]; LEMMO ANTHONY V [US]; MONAGLE JULIE [US]
Patent No.: US7449511B2 Issued: 11/Nov/2008Title: Polymeric thickeners for oil-containing compositions
Applicant/Assignee: LANDEC CORP
Application No.: 11/199508 Filing Date: 08/Aug/2005
Abstract:
Thickeners for oil-containing compositions, particularly cosmetic and personal care compositions, are side chain crystalline polymers which are uniformly dispersed as a crystallized solid in the oil.
Priority: WO2000US40780 Applic. Date: 2000-08-30; US2001-810920 Applic. Date: 2001-03-16; US1999-398377 Applic. Date: 1999-09-17
Inventor: BITLER STEVEN P [US]; TAFT DAVID D [US]
Patent No.: US7449613B2 Issued: 11/Nov/2008Title: Film-forming compositions for protecting skin from body fluids and articles made therefrom
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 11/273355 Filing Date: 14/Nov/2005
Abstract:
The present invention relates to a film-forming barrier composition useful for protecting the skin from body fluids, such as urine, feces, menses. The composition comprises a skin conditioning agent, a viscosity enhancing agent and an oleophilic film-forming agent. Optionally, the lotion may comprise skin care ingredients for treating or maintaining skin health. The composition may be applied to the skin by suitable delivery vehicles, such as absorbent articles or components thereof, sheet materials, pads, bandages, sponges, foam pads, pumps, sprays, depending on the viscosity of the composition.
Priority: US2001-898880 Applic. Date: 2001-07-03
Inventor: KLOFTA THOMAS JAMES [US]; STAUDIGEL JAMES ANTHONY [US]; DECKNER GEORGE ENDEL [US]
Patent No.: US7452545B2 Issued: 18/Nov/2008Title: Oligosaccharide aldonic acids and their topical use
Applicant/Assignee:
Application No.: 10/811998 Filing Date: 30/Mar/2004
Abstract:
Compositions comprising oligosaccharide aldonic acids are useful for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and/or extrinsic aging, as well as with changes or damage caused by extrinsic factors
general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa
for general oral care, as well as treatment and prevention of oral and gum diseases
and for wound healing of the skin. Compositions comprising oligosaccharide aldonic acids may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Priority: US2001-987023 Applic. Date: 2001-11-13
Inventor: YU RUEY J [US]; VAN SCOTT EUGENE J [US]
Patent No.: US7455725B2 Issued: 25/Nov/2008Title: Washable marker ink composition
Applicant/Assignee: MATTEL, INC
Application No.: 10/944980 Filing Date: 20/Sep/2004
Abstract:
The present invention provides a fluorescent marker ink coloring composition incorporating an optical brightener, a film-forming agent, an aqueous carrier, and a colorant. The optical brightener is an amphoteric distyryl fluorescent whitener which generates a special effect in the dried marking ink composition. The coloring composition can optionally include one or more of a humectant, a surfactant, a preservative, a drying agent, a pH regulant, a bittering agent or a fragrance. The present invention further provides a writing instrument comprising the coloring composition.
Priority:
Inventor: CORDOVA ABIMAEL [US]
Patent No.: US7455848B2 Issued: 25/Nov/2008Title: Skin care composition containing an anionic polymer
Applicant/Assignee: NALCO COMPANY
Application No.: 10/323217 Filing Date: 18/Dec/2002
Abstract:
A cosmetically acceptable composition for treating skin comprising about 0.1 to about 20 weight percent, based on polymer solids, of an anionic polymer composed of from about 10 to about 80 mole percent of 2-acrylamido-2-methyl-1-propanesulfonic acid or a base addition salt thereof and from about 90 to about 20 mole percent of one or more anionic or nonionic monomers.
Priority:
Inventor: HESSEFORT YIN Z [US]; BETTS DOUGLAS [US]; CARLSON WAYNE M [US]; BRANDT LORALEI [US]; SMITH JENNIFER L [US]
Patent No.: US7456331B2 Issued: 25/Nov/2008Title: Composition for cushions, wounds dressings and other skin-contacting products
Applicant/Assignee: A.V. TOPCHIEV INSTITUTE OF PETROCHEMICAL SYNTHESIS, RUSSIAN ACADEMY OF SCIENCES CORIUM INTERNATIONAL, INC
Application No.: 11/594461 Filing Date: 07/Nov/2006
Abstract:
A skin-contacting adhesive composition is described which has improved initial tack, long-term adhesion, water uptake and translucency characteristics and may be prepared by melt extrusion. Uses of these compositions are also described, for example, their use in wound dressings, adhesive cushions, and transdermal drug delivery devices.
Priority: US2002-227623 Applic. Date: 2002-08-21; US20020383504P Applic. Date: 2002-05-24
Inventor: KULICHIKHIN VALERY G [RU]; PARANDOOSH SHOREH [US]; FELDSTEIN MIKHAIL M [RU]; ANTONOV SERGEY [RU]; CLEARY GARY W [US]
Patent No.: US7458982B2 Issued: 02/Dec/2008Title: Photokinetic delivery of biologically active substances using pulsed incoherent light
Applicant/Assignee: PHOTOKINETIX, INC
Application No.: 10/679112 Filing Date: 03/Oct/2003
Abstract:
The invention relates generally to transdermal and transmembrane delivery of biologically active substances through the skin, sub-dermal tissues, blood vessels and cellular membranes without causing damage to the cellular surface, tissue or membrane. The invention provides compositions and methods for enhanced transdermal and transmembrane delivery of biologically active substances using pulsed incoherent light. The invention further provides a device for the application of the pulsed incoherent light to cellular surfaces and membranes using those compositions and methods.
Priority: US20020416361P Applic. Date: 2002-10-04; US20030479501P Applic. Date: 2003-06-17
Inventor: KRAFT EDWARD R [US]; KULP GABRIELA [US]
Patent No.: US7459283B2 Issued: 02/Dec/2008Title: Nanoparticulate compositions having lysozyme as a surface stabilizer
Applicant/Assignee: ELAN PHARMA INTERNATIONAL LTD ELAN PHARMA INTERNATIONAL LIMITED
Application No.: 10/357514 Filing Date: 04/Feb/2003
Abstract:
The present invention is directed to nanoparticulate active agent compositions comprising lysozyme as a surface stabilizer. Also encompassed by the invention are pharmaceutical compositions comprising a nanoparticulate active agent composition of the invention and methods of making and using such nanoparticulate and pharmaceutical compositions.
Priority: US20020353230P Applic. Date: 2002-02-04
Inventor: WERTZ CHRISTIAN F [US]; RYDE NIELS P [US]
Patent No.: US7462589B2 Issued: 09/Dec/2008Title: Delivery system for uniform deposition of fabric care actives in a non-aqueous fabric treatment system
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 10/876032 Filing Date: 24/Jun/2004
Abstract:
A delivery system for uniform deposition of fabric care actives to a fabric article in a non-aqueous solvent based fabric treatment process
and compositions capable of uniformly depositing the fabric care actives on the fabric article being treated to achieve maximum benefit.
Priority: US20040547369P Applic. Date: 2004-02-24; US20030483392P Applic. Date: 2003-06-27
Inventor: BAKER KEITH HOMER [US]; O'NEIL JULIE ANN [US]; ARREDONDO VICTOR MANUEL [US]; GARDNER ROBB RICHARD [US]; DUPONT JEFFREY SCOTT [US]; SIVIK MARK ROBERT [US]; HOPKINS JEFFREY JON [US]; SCHEPER WILLIAM MICHAEL [US]
Patent No.: US7468421B2 Issued: 23/Dec/2008Title: Depilatories and agents for external use
Applicant/Assignee: KAO CORPORATION
Application No.: 11/026090 Filing Date: 03/Jan/2005
Abstract:
This invention relates to depilatories and external preparations, each of which contains endothelin or its agonist, and also to a depilating method characterized by administering endothelin or its agonist. As the depilatories and external preparations according to the present invention inhibit growth of hair in mammalian skin, their application to the human body as drugs or cosmetics permits safe and effective removal of hair from the body. These depilatories and external preparations are also usable as wool harvesting preparations.
Priority: JP19990299305 Applic. Date: 1999-10-21; US2002-110226 Applic. Date: 2002-08-15; WO2000JP07218 Applic. Date: 2000-10-18
Inventor: OHUCHI ATSUSHI [JP]; KOBAYASHI AKEMI [JP]; HACHIYA AKIRA [JP]
Patent No.: US7470434B1 Issued: 30/Dec/2008Title: Methods and compositions for blocking microbial adherence to eukaryotic cells
Applicant/Assignee:
Application No.: 11/881622 Filing Date: 28/Jul/2007
Abstract:
A method of blocking microbial adherence to a eukaryotic cell surface in a mammal by applying a pharmacologically acceptable composition containing at least one compound selected from the group consisting of isoleucine, an active isomer thereof, and an active analog thereof, to said surface in a microbial blocking quantity. Also, compositions for achieving the above blocking of microbial adherence.
Priority:
Inventor: ZASLOFF MICHAEL A [US]; ANDERSON GLENN M [US]
Patent No.: US7470675B2 Issued: 30/Dec/2008Title: Methods for treating cancer using interferon-omega-expressing polynucleotides
Applicant/Assignee: VICAL INCORPORATED
Application No.: 11/709868 Filing Date: 23/Feb/2007
Abstract:
The present invention provides a pharmaceutical composition, comprising a non-infectious, non-integrating polynucleotide construct comprising a polynucleotide encoding an interferon omega and one or more cationic compounds. The present invention also provides methods of treating cancer in a mammal, comprising administering into a tissue of the mammal a non-infectious, non-integrating polynucleotide construct comprising a polynucleotide encoding a cytokine. In addition, the present invention also relates to the methodology for selective transfection of malignant cells with polynucleotides expressing therapeutic or prophylactic molecules in intra-cavity tumor bearing mammals. More specifically, the present invention provides a methodology for the suppression of an intra-cavity dissemination of malignant cells, such as intraperitoneal dissemination.
Furthermore, the invention relates to compositions and methods to deliver polynucleotides encoding polypeptides to vertebrate cells in vivo, where the composition comprises an aqueous solution of sodium phosphate.
Priority: US2000-557907 Applic. Date: 2000-04-21; US1998-196313 Applic. Date: 1998-11-20; US19970067087P Applic. Date: 1997-11-20; US19980079914P Applic. Date: 1998-03-30; US19980100820P Applic. Date: 1998-09-15
Inventor: HORTON HOLLY [US]; PARKER SUEZANNE [US]; MANTHORPE MARSTON [US]; FELGNER PHILIP L [US]; HARTIKKA JUKKA [US]